Published on
08:30 GMT
Delhi HC denies interim injunction on Roche rare disease drug, opening the door for generic versions
Patients with Spinal Muscular Atrophy (SMA) are hopeful of getting access to generic versions of Roche’s patented drug Risdiplam, following Delhi High Court’s denial of an interim injunction request from the Swiss drugmaker. The legal development has …
Source:
The Hindu Business Line
-
Neutral
